XOLAIR® 150mg

Manufacturer: Novartis
Active Substance(s): OMALIZUMAB
Strength: 150ml
Pack Size: 1 x 150ml Powder Vial
XOLAIR® (omalizumab) for subcutaneous use is an injectable prescription medicine used to treat chronic rhinosinusitis with nasal polyps (CRSwNP) in people 18 years of age and older when medicines to treat CRSwNP called nasal corticosteroids have not worked well enough.

See product leaflet